» Articles » PMID: 11967553

Listening to Silence and Understanding Nonsense: Exonic Mutations That Affect Splicing

Overview
Journal Nat Rev Genet
Specialty Genetics
Date 2002 Apr 23
PMID 11967553
Citations 882
Authors
Affiliations
Soon will be listed here.
Abstract

Point mutations in the coding regions of genes are commonly assumed to exert their effects by altering single amino acids in the encoded proteins. However, there is increasing evidence that many human disease genes harbour exonic mutations that affect pre-mRNA splicing. Nonsense, missense and even translationally silent mutations can inactivate genes by inducing the splicing machinery to skip the mutant exons. Similarly, coding-region single-nucleotide polymorphisms might cause phenotypic variability by influencing splicing accuracy or efficiency. As the splicing mechanisms that depend on exonic signals are elucidated, new therapeutic approaches to treating certain genetic diseases can begin to be explored.

Citing Articles

Identification of diagnostic and prognostic genetic alterations in uveal melanoma using RNA sequencing.

Nell R, Versluis M, Cats D, Mei H, Verdijk R, Kroes W Sci Rep. 2025; 15(1):8167.

PMID: 40059100 PMC: 11891316. DOI: 10.1038/s41598-025-90122-z.


Alternative Splicing as a Modulator of the Interferon-Gamma Pathway.

Suri P, Badalov A, Ruggiu M Cancers (Basel). 2025; 17(4).

PMID: 40002189 PMC: 11853465. DOI: 10.3390/cancers17040594.


Development of single nucleotide polymorphisms in key genes of taurine and betaine metabolism in Crassostrea hongkongensis and their association with content-related traits.

Kong L, Chen Z, Jia Z, Deng Q, Zhu P, Xu Y BMC Genomics. 2025; 26(1):184.

PMID: 39994554 PMC: 11849188. DOI: 10.1186/s12864-025-11373-8.


Alternative Splicing at the Crossroad of Inflammatory Bowel Diseases and Colitis-Associated Colon Cancer.

Matos P, Jordan P Cancers (Basel). 2025; 17(2).

PMID: 39858001 PMC: 11764256. DOI: 10.3390/cancers17020219.


Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy.

Tzaban S, Stern O, Zisman E, Eisenberg G, Klein S, Frankenburg S Front Immunol. 2025; 15():1490035.

PMID: 39845971 PMC: 11752881. DOI: 10.3389/fimmu.2024.1490035.